Ikena Oncology Inc reports results for the quarter ended in June - Earnings Summary

ImageneBio

11/08/2022 14:34

* Ikena Oncology Inc  IKNA.OQ  reported a quarterly adjusted
loss
of 57 cents​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 49 cents per share.
    * Revenue fell 89.2% to $382.00 thousand from a year ago;
analysts
expected $3.87 million. 
    * Ikena Oncology Inc's reported EPS for the quarter was a
loss
of 57 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Ikena Oncology Inc shares had risen by 17.8% this
quarter and
lost 58.4% so far this year.
    * The company reported a quarterly loss of $20.49 million.
    * Wall Street's median 12-month price target for Ikena
Oncology
Inc is $26.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 01:34 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.49          -0.57          Missed
 Mar. 31 2022      -0.42          -0.47          Missed
 Dec. 31 2021      -0.51          0.07           Beat
 Sep. 30 2021      -0.42          -0.40          Beat